*January 2022*
In this video, EGFR Resisters co-founder Jill Feldman discusses this topic with Dr. Jorge J Nieva of USC Norris Comprehensive Cancer Center.
We are a group of lung cancer patients with EGFR mutations who have developed resistance to at least one targeted treatment drug, or who face probable resistance in the future. Caregivers are also welcome. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.